Assessment of the Clinical Efficacy and Acceptability of Think Positive (T+) in Diabetes Management
T+
1 other identifier
interventional
86
1 country
1
Brief Summary
New telemedicine systems have been designed to assist people suffering from diabetes in the management of their chronic disease. More recently the focus has been moving to portable systems equipped with Bluetooth. This study consists of evaluating an application called the Think Positive (T+) diabetes management software. It is a randomized controlled trial designed to compare, over a nine month period, a group of patients receiving usual care with a group of patients using the T+ system. The objectives of the study are to investigate the extent to which this telemedicine application helps patients control their blood sugar levels (HbA1c), as well as the extent to which its users consider it to be acceptable. The impact of its use on factors such as diabetes self-care, health status, quality of life, self-confidence in diabetes management, fear of hypoglycemia and illness representations will also be examined. Because of the supplementary real-time support and feedback that T+ offers, its use should lead to better outcomes in diabetes management than usual care does.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2009
CompletedFirst Posted
Study publicly available on registry
June 17, 2009
CompletedStudy Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2011
CompletedApril 10, 2012
April 1, 2012
1.4 years
June 16, 2009
April 9, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Blood sugar levels (HbA1c)
Baseline, 3 months, 9 months
Secondary Outcomes (13)
BMI
Baseline, 3 months, 9 months
Number of Hypoglycemic events
Baseline, 3 months, 9 months
Blood pressure
Baseline, 3 months, 9 months
Diabetes self-care
Baseline, 3 months, 9 months
Diabetes self- efficacy
Baseline, 3 months, 9 months
- +8 more secondary outcomes
Study Arms (2)
T+ Intervention
ACTIVE COMPARATORThe intervention group patients will use the T+ telemedicine application whilst completing repeated measures aiming to compare them to a control group receiving standard care.
Usual care
NO INTERVENTIONThe control group will be receiving the standard care offered by the NHS to patients suffering from diabetes.
Interventions
T+ consists of the Glucometer paired with a cradle that transmits via Bluetooth blood glucose results to a mobile phone. Data is stored and sent to a secure website. The website can be accessed by the patient as well as by health care providers (HCP). HCP can discuss data on the phone and make recommendations via text messages to patients. Visual feedback (graphs and statistics) illustrating recent blood sugar levels patterns is automatically and immediately sent to the patient when data is transferred from the T+ phone.
Eligibility Criteria
You may qualify if:
- Type 1 and type 2 diabetes patients
- Insulin requiring patients
- Sufficiently fluent in english
- HbA1c \> 7.5
- Last visit with Diabetes Specialist Nurse (DSN) \< 12 months
You may not qualify if:
- Psychiatric disorders
- Poor vision or/and lack of manual dexterity
- Prior use of T+
- Participation in another ongoing trial
- Patients with antenatal/gestational
- Patients who are in transition between the children services and adult services Insulin pump users
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University College London Hospitalslead
- University College, Londoncollaborator
- Department of Health, United Kingdomcollaborator
Study Sites (1)
University College London (UCL)
London, W1W 7EJ, United Kingdom
Related Publications (7)
Blake H. Mobile phone technology in chronic disease management. Nurs Stand. 2008 Nov 26-Dec 2;23(12):43-6. doi: 10.7748/ns2008.11.23.12.43.c6728.
PMID: 19093357BACKGROUNDFarmer A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med. 2005 Oct;22(10):1372-8. doi: 10.1111/j.1464-5491.2005.01627.x.
PMID: 16176199BACKGROUNDFaridi Z, Liberti L, Shuval K, Northrup V, Ali A, Katz DL. Evaluating the impact of mobile telephone technology on type 2 diabetic patients' self-management: the NICHE pilot study. J Eval Clin Pract. 2008 Jun;14(3):465-9. doi: 10.1111/j.1365-2753.2007.00881.x. Epub 2008 Mar 24.
PMID: 18373577BACKGROUNDJaana M, Pare G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007 Apr;13(2):242-53. doi: 10.1111/j.1365-2753.2006.00686.x.
PMID: 17378871BACKGROUNDKollmann A, Riedl M, Kastner P, Schreier G, Ludvik B. Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. J Med Internet Res. 2007 Dec 31;9(5):e36. doi: 10.2196/jmir.9.5.e36.
PMID: 18166525BACKGROUNDWangberg SC, Arsand E, Andersson N. Diabetes education via mobile text messaging. J Telemed Telecare. 2006;12 Suppl 1:55-6. doi: 10.1258/135763306777978515.
PMID: 16884582BACKGROUNDBaron J, Hirani S, Newman S. A mobile telehealth intervention for adults with insulin-requiring diabetes: early results of a mixed-methods randomized controlled trial. JMIR Res Protoc. 2015 Feb 26;4(1):e27. doi: 10.2196/resprot.4035.
PMID: 25803226DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
June 16, 2009
First Posted
June 17, 2009
Study Start
June 1, 2010
Primary Completion
November 1, 2011
Study Completion
November 1, 2011
Last Updated
April 10, 2012
Record last verified: 2012-04